Product Description and Product Data
This is an all-inclusive cell-based luciferase reporter assay kit targeting the Dog Peroxisome Proliferator-Activated Receptor Alpha. INDIGO’s dPPAR alpha reporter assay utilizes proprietary non-human mammalian cells that have been engineered to provide constitutive expression of the dPPAR alpha. In addition to dPPAR alpha Reporter Cells, this kit provides two optimized media for use during cell culture and in diluting the user’s test samples, a reference agonist, Luciferase Detection Reagent, and a cell culture-ready assay plate. The principal application of this assay is in the screening of test samples to quantify any functional activity, either agonist or antagonist, that they may exert against dPPAR alpha. This kit provides researchers with clear, reproducible results, exceptional cell viability post-thaw, and consistent results lot to lot. Kits must be stored at -80C. Do not store in liquid nitrogen. Note: reporter cells cannot be refrozen or maintained in extended culture.
Features
Clear, Reproducible Results
- All-Inclusive Assay Systems
- Exceptional Cell Viability Post-Thaw
- Consistent Results Lot to Lot
Product Specifications
Target Type | Nuclear Hormone Receptor, Nuclear Receptor Orthologs | ||
Species | Dog | ||
Receptor Form | Hybrid | ||
Assay Mode | Agonist, Antagonist | ||
Kit Components |
| ||
Shelf Life | 6 months | ||
Shipping Requirements | Dry Ice | ||
Storage temperature | -80C |
Data
Target Background
INDIGO’s Dog Peroxisome Proliferator-Activated Receptor Alpha (dPPARα) Reporter Assay System utilizes proprietary mammalian cells engineered to provide constitutive, high-level expression of Dog PPARα (nr1c1), a ligand-dependent transcription factor. Because these cells incorporate a responsive luciferase reporter gene, quantifying expressed luciferase activity provides a sensitive surrogate measure of dPPARα activity in treated cells. The primary application of this reporter assay system is in the screening of test samples to quantify functional activity, either agonist or antagonist, that they may exert against dog PPARα.
Product Documentation
Also available as a service